SCHEMBL526708

SCHEMBL526708

CS(=O)(=O)N(c1ccccc1)c1ccc(-c2cnccc2-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.47
RPS6KA3 P51812 5/20 0.47
PTGS2 P35354 4/20 0.47
CYP46A1 Q9Y6A2 1/20 0.43
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
FGFR1 P11362 1/20 0.39
SRC P12931 1/20 0.39
FGFR2 P21802 1/20 0.39
FGFR4 P22455 1/20 0.39
FGFR3 P22607 1/20 0.39
PKM P14618 1/20 0.38
SLC22A12 Q96S37 2/20 0.38
IKBKB O14920 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2E1 P05181 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C8 P10632 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2A6 P11509 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8716812 0.76 RPS6KA3 (0.65) CYP17A1RPS6KA3CYP46A1MAOAMAOB
SCHEMBL527072 0.75 PTGS2 (0.50) CYP17A1PTGS2SLC22A12CYP3A4PTGS1
SCHEMBL17952942 0.75 RPS6KA3 (0.49) RPS6KA3CYP46A1MAOAMAOBSLC22A12
SCHEMBL17952764 0.75 RPS6KA3 (0.49) CYP17A1RPS6KA3CYP46A1MAOAMAOB
SCHEMBL1704542 0.74 PKM (0.50) PKM
SCHEMBL21692174 0.72 RPS6KA3 (0.59) CYP17A1RPS6KA3CYP46A1MAOAMAOB
SCHEMBL21692148 0.72 RPS6KA3 (0.59) CYP17A1RPS6KA3CYP46A1MAOAMAOB
SCHEMBL7045230 0.71 RPS6KA3 (0.57) CYP17A1RPS6KA3PTGS2CYP46A1SLC22A12
SCHEMBL6728690 0.70 RPS6KA3 (0.63) CYP17A1RPS6KA3PTGS2SLC22A12GPBAR1
SCHEMBL5700364 0.70 PTGS2 (0.51) CYP17A1PTGS2MAOAMAOBFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP claimed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO claimed
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP disclosed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed